ISSN: 2161-1459

Journal of Clinical & Experimental Pharmacology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
 
 
 

Editorial Board

Y W Francis Lam

Editor-in-Chief
Y W Francis Lam
Professor
Department of Pharmacology
The University of Texas
USA

Biography :

Dr. Lam is Professor of Pharmacology at University of Texas Health Science Center at San Antonio, USA. He is also the James O Burke Endowed Centennial Fellow in Pharmacy and Clinical Associate Professor at University of Texas at Austin. Dr. Lam received his B.Pharm. degree from University of Bradford, England, and Pharm.D. degree from University of Minnesota, USA. He is an elected Fellow of the American College of Clinical Pharmacy and Councilor of the Pacific Rim Association of Clinical Pharmacogenetics, and currently serves on the editorial board of the Open Drug Metabolism Journal. He is the leading editor of two books related to the Clinical Pharmacology discipline.

 Biography
Research Interest :

Drug metabolism
Clinical pharmacology
Pharmacokinetics
Pharmacogenetics

 Research Interest
 Network
Francisco Lopez-Munoz

Co-Editor-in-Chief
Francisco Lopez-Munoz
Professor
Camilo Jose Cela University
Spain

Biography :

Francisco Lopez-Munoz studied Medicine at Complutense University (Madrid). He received his PhD Degree in Medicine at Complutense University in 1993, with a Thesis on postnatal development of the rat pineal gland after chemical denervation that won the Doctorate Extraordinary Award. During her pre- and post-doctoral training, he worked in neurohistology at the Department of Cellular Biology of the Complutense University. He is specialist in Pharmaceutical Medicine. Between 1992 and 2009, he worked in the pharmaceutical industry (Juste, S.A.Q.F.), as Medical Director. After 1996 he is honorary research Professor at the Pharmacology Department of the University of Alcala, working primarily in the field of neuropsychopharmacology. Currently, he is Professor of Pharmacology at Camilo Jose Cela University (Madrid). Dr. Lopez-Munoz is editor/author of 14 books, highlighting its History of Psychopharmacology (3 volumes; Editorial Medica Panamericana, 2007), and Neurobiology of Depression (Taylor & Francis Group LLC, in press), and 138 chapters of books related to the psychopharmacology. He has published 105 papers on indexed journals with impact factor and 163 in Spanish journals. He has participated in 108 scientific meetings, and is member of many scientific societies (including Collegium Internationale Neuro-Psychopharmacologicum) and editorial boards, including European Journal of Pharmacology and Frontiers in Psychopharmacology. Dr. Lopez-Munoz has participated, as visiting Professor and Director, in postgraduate and doctorate courses from different Spanish academic centres.

 Biography
Research Interest :

His main research lines have been the postnatal development of mammals pineal gland after chemical sympathectomy, the biological bases of drug abuse and dual diagnosis, the psychotropic drugs interactions, the neurobiology of aggressivity, the bibliometric techniques applied to mental health-related disciplines and neuropsychopharmacology, the combination therapies with antidepressant drugs in resistant depression and with antipsychotics drugs in patients with refractory schizophrenia, and the history of the psychopharmacology.

 Research Interest
 Network
 Acceptance Letter
Q Ping Dou

Q Ping Dou
Professor
Oncology, Pharmacology and Pathology
Wayne State University
USA

Biography :

Dr. Q. Ping Dou is Professor of Oncology, Pharmacology and Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI. Dr. Dou obtained his B.S. degree in chemistry from Shandong University in 1981, Ph.D. degree in chemistry from Rutgers University in 1988, and postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School from 1988 to 1993 (Mentor: Arthur B. Pardee). Dr. Dou has extensive experience in the fields of drug discovery, chemoprevention, natural products, proteasome inhibitors, cell cycle and apoptosis. He has published ~214 peer-reviewed research and review articles, many of those in journals of the highest quality, and also holds more than 10 patents. He has extensive experience in professional service, including various study sections, several advisory and editorial boards, and committees. He has mentored numerous graduate students, post-doctoral fellows and junior faculty.

 Biography
Research Interest :

Dr. Dou’s commitment to cancer research is centered on targeted therapies, drug discovery, natural products, and chemoprevention. The main objective in his laboratory is aimed at discovering molecular targets of natural and synthetic small molecules in pre-clinical studies, followed by validation in targeted clinical trials. His laboratory is one of the first to report that proteasome inhibitors rapidly induce tumor cell apoptosis, selectively activate the cell death program in oncogene-transformed, but not normal or untransformed cells, and are able to trigger apoptotic death in human cancer cells that are resistant to various anticancer agents. His laboratory has also shown that some tea polyphenols, curcumin, DIM, medicinal compounds and metal complexes potently and specifically inhibit the chymotrypsin-like activity of the proteasome in vitro and in vivo. Most recently, he has found that (i) novel epigallocatechin gallate (EGCG) analogs and BR-DIM activate AMP-activated protein kinase (AMPK) pathway, target cancer stem cells and induce apoptosis; (ii) novel EGCG and curcumin analogs increase efficacy of bortezomib (BTZ) in human multiple myeloma (MM) cells.

 Research Interest
 Network
Peter James Little

Peter James Little
Head
Pharmacy
University of Queensland
Australia

Biography :

Peter is currently Head, School of Pharmacy, The University of Queensland. Peter completed a B. Pharm. at the Victorian College of Pharmacy (now Monash) followed by an M. Sc. and Ph. D. at The University of Sydney and Post-Doctoral training at the National Institutes of Health (USA). Peter’s research has centred on the cardiovascular complications of diabetes, specifically the role of modified proteoglycans in lipid deposition diseases such as atherosclerosis. After a 20 year career at the BakerIDI Heart and Diabetes Institute and Alfred Health, in 2010 Peter became the Foundation Head of Pharmacy at RMIT University, in Melbourne. In this context Peter added Pharmacy Practice to his research areas of interest. In June 2015, Peter became Head of the School of Pharmacy at The University of Queensland (UQ) and moved his research laboratory to the Pharmacy Australia Centre of Excellent (PACE) at UQ. Peter is Professor and Dean (Visiting) of Pharmacy at Xinhua College of Sun Yat-sen University and a High end Foreign Expert through Sun Yat-sen University in Guangzhou, China. Peter is a former National President of Diabetes Australia and was Founding Secretary and later President of The Australian Vascular Biology Society. In 2007, Peter received an Order of Australia (“AM”) for services to people with diabetes and diabetes research.

 Biography
Research Interest :

Peter's research interests are the cardiovascular complications of diabetes and signalling pathways controlling the synthesis and structure of proteoglycans and glycosaminoglycans as they relate to lipid retention diseases such as atherosclerosis and dry age-related macular degeneration.

 Research Interest
 Network
Swapan K Ray

Swapan K Ray
Professor
Department of Pathology
University of South Carolina
USA

Biography :

Dr. Swapan K. Ray received his Ph.D. in Biochemistry from the University of Calcutta, India. Dr. Ray did his postdoctoral training at the Brookhaven National Laboratory. He held faculty positions at the Emory University and the Medical University of South Carolina before moving to the University of South Carolina. He is currently a Professor in the Department of Pathology, Microbiology, and Immunology at the University of South Carolina School of Medicine.
 

 Biography
Research Interest :

Dr. Ray’s research interest includes the understanding of the cellular and molecular mechanisms of pathogenesis of malignant diseases such as glioblastoma, neuroblastoma, and Ewing′s sarcoma and also neurodegenerative disorders such as spinal cord injury, brain ischemia, traumatic brain injury, Alzheimer′s disease, amyotropic lateral sclerosis, epilepsy, glaucoma,parkinson′s disease, and multiple sclerosis and also development of novel therapeutic strategies for their treatments in preclinical models.
 

 Research Interest
 Network
 Acceptance Letter
Aron D Mosnaim

Aron D Mosnaim
Professor
Department of Molecular Pharmacology
Rosalind Franklin University
USA
Read Interview session with Aron D Mosnaim

Biography :

Dr. Mosnaim was awarded a Doctor of Pharmaceutical Sciences degree from the University of Chile and supported by a British Council Fellowship, a Ph.D. degree in Organic Chemistry from Glasgow’s Strathclyde University. After postdoctoral training at the University of Chicago and Northwestern University, Dr. Mosnaim joined the faculty of Rosalind University of Medicine and Science/The Chicago Medical School where he currently holds a tenured Professorship in the Department of Cellular and Molecular Pharmacology and an Adjunct Professorship in Psychiatry and Behavioral Sciences. Dr. Mosnaim also holds and Honorary Professorship at the University of Chile. Dr. Mosnaim has co-authored over three hundred and fifty scientific papers, published abstracts and book chapters.

 Biography
Research Interest :

Biochemical, molecular and clinical pharmacology of biogenic amines, particularly phenylethylamine and related noncatecholic phenylethylamines. Pathophysiology of tardive dyskinesia and other movement disorders. Vasoactive amines, endogenous peptides with opioid-like properties and the immune system in migraine and cluster headaches. Triptan drugs and the immune system. Endogenous peptides and the immune system in stress-related disorders e.g., post traumatic stress disorder and septic shock. Stress, endogenous peptides and asthma. Matrix metalloproteinases as markers for various neurological disorders, including vascular lesions, demyelination, inflammatory, degenerative and prion diseases.

 Research Interest
 Network
Chang-Guo Zhan

Chang-Guo Zhan
Professor
Department of Pharmaceutical Sciences
University of Kentucky
USA

Biography :

Dr. Chang-Guo Zhan is Professor of Pharmaceutical Sciences in the College of Pharmacy, University of Kentucky. Dr. Zhan received a Ph.D. in Chemistry from University of Notre Dame and a Ph.D. in Science from Institute for Molecular Science IMS, Japan. Dr. Zhan performed his postdoctoral research training as a Postdoctoral Research Scientist at Department of Medicine, Columbia University. Dr. Zhan joined the UK College of Pharmacy faculty as Associate Professor and was promoted to Professor. Dr. Zhan was elected as Fellow of the American Association of Pharmaceutical Scientists AAPS. Dr. Zhan is a winner of Emerging Computational Technology Prize, American Chemical Society ACS Division of Computers in Chemistry. He has served as Chair of AAPS Computational Drug Design Focus Group and on AAPS National Biotechnology Conference Programming Committee.

 Biography
Research Interest :

Dr. Zhan’s current research interests include: Rational drug design and discovery; drug development; molecular pharmacology; pharmacokinetic modeling; medicinal chemistry; computational chemistry.

 Research Interest
 Network
William R Ravis

William R Ravis
Professor
Department of Pharmacal Sciences
Auburn University
USA
Read Interview session with William R Ravis

Biography :

William R. Ravis is a Professor of Pharmaceutics in the Department of Pharmacal Sciences, Harrison School of Pharmacy of Auburn University and Adjunct Professor in the Department of Physiology and Pharmacology at the College of Veterinary Medicine at Auburn University. He received a B.S. in Pharmacy from Temple University and a Ph.D. from the University of Houston in the area of Biopharmaceutics/Biophysics. In 1977, he joined the faculty at Auburn University’s School of Pharmacy and was appointed Department Head of the Department of Pharmacal Sciences from 1990-2007. He has authored over 130 research publications and book chapters covering areas of human and veterinary pharmacokinetics, bioequivalency, novel drug delivery, drug interactions, stereo-selectivity, drug metabolism, plasma protein binding, and modeling. He is a Fellow of the American College of Clinical Pharmacology. William serves and has served on numerous editorial boards and is a reviewer for over 15 research journals.

 Biography
Research Interest :

Biopharmaceutics, Drug delivery, Pharmacokinetics, Micro/nanoparticles, Clinical trials

 Research Interest
 Network
 Acceptance Letter
Li-Na Wei

Li-Na Wei
Professor
Department of Pharmacology
University of Minnesota
USA

Biography :

Li-Na Wei received her Ph.D. in Microbiology from Texas Tech University Health Science Center at Lubbock, and post-doctoral training from Medicine/Microbiology at Columbia University at New York. She joined the faculty of Dept. Pharmacology at University of Minnesota Medical School as an Assistant Professor, rose to the rank of Full Professor, and was named Distinguished McKnight University Professor of the University of Minnesota. She has organized several international meetings including FASEB conferences on Retinoid, and INRC, and is in editorial board for Nature Publishing group Molecular Page, Adipocyte, J. Exp. Pharmacology, and Gene Regulation & System Biology.

 Biography
Research Interest :

Research interest in her lab focuses on transcriptional and post-transcriptional regulation of gene/protein expression in neurons and embryonic stem cells, and in cellular differentiation processes of neurons and adipocytes. The experimental models examine specific functional roles of RIP140, orphan nuclear receptors and opioid receptors in the development of metabolic diseases as well as neurological disorders. The ultimate goal is to understand the integration of various biological processes occurred in different sub-cellular compartments through the action of specific regulators and signaling pathways in the context of functional cells and in whole animals.
 
 

 Research Interest
 Network
 Acceptance Letter
S Hossein Fatemi

S Hossein Fatemi
Professor
Division of Neuroscience Research
University of Minnesota
USA

Biography :

Dr. S.H. Fatemi is currently an Associate Head for Neuroscience and Translational Research in the Department of Psychiatry at the University of Minnesota Medical School. Moreover, he is a Professor of Psychiatry, Pharmacology, and Neuroscience. He received his Ph.D. in Human Anatomy from the University of Nebraska Medical Center and his M.D. from Case Western Reserve University Medical School. Over the last 15 years, his research has been focused on the identification and elucidation of etiologies for major psychiatric disorders such as Schizophrenia and Autism, as well as mood disorders.

 Biography
Research Interest :

Development of animal models of psychiatric disorders and mapping of brain genes and proteins that may be important in the etiology and treatment of these disorders.

 Research Interest
 Network
Brian K Alldredge

Brian K Alldredge
Professor
Clinical Pharmacy and Neurology
The University of California
USA

Biography :

Dr. Alldredge is a Professor of Clinical Pharmacy and Neurology at the University of California, San Francisco and a member of the UCSF Epilepsy Center. He is an editor of Applied Therapeutics: The Clinical Use of Drugs - a pharmacotherapy text book used widely in health professions education, which was recently published in its 10th edition. He participates on invited review groups for the National Institutes of Neurological Disorders & Stroke, and he serves as a reviewer for journals in pharmacy, neurology and medicine. His research has been funded by the National Institutes of Health and professional organizations. In his role as Associate Dean, Academic Affairs for the School of Pharmacy, Dr. Alldredge serves on numerous committees and task forces related to faculty development, faculty life, and academic diversity.

 Biography
Research Interest :

His clinical practice and research interests focus on epilepsy, seizure emergencies, prehospital care, and pharmacogenomics.

 Research Interest
 Network
 Acceptance Letter
Hussein D Foda

Hussein D Foda
Professor
Department of Pulmonary and Critical Care Medicine
Stony Brook University
USA

Biography :

Dr Hussein D Foda, MD, is Professor of Medicine at the Division of Pulmonary and Critical Care Medicine at the Stony Brook State University of New York’s School of Medicine and the Director of the Pulmonary/Critical Care Fellowship program. He is also Chief of Medicine and Associate Chief of Staff for Research at Northport VA Medical Center in Northport, New York. He has previously held academic and clinical appointments at the University of Illinois at Chicago and the University of Illinois Hospital and West Side VAMC, Chicago. Dr Foda holds specialty and sub-specialty board certifications in critical care medicine and pulmonary disease in addition to certification by the American Board of Internal Medicine, and is licensed to practice in five US states and Egypt. He is the author of 37 peer reviewed articles and 51 abstracts and presentations at scientific meetings.

 Biography
Research Interest :

Pulmonology, Critical Care Medicine.

 Research Interest
 Network
Rakesh K Srivastava

Rakesh K Srivastava
Professor
Department of Pharmacology
The University of Kansas
USA

Biography :

Dr. Rakesh K Srivastava Currently, he is working as Professor, Department of Pharmacology, University of Kansas, USA. Based on this research and fellowship training he has received several awards and honors. He is serving as an editorial member of several reputed journals like Clinical & Experimental Pharmacology.

 Biography
Research Interest :

Cancer therapy, prevention, stem cell, drug discovery and development, cell signaling, metastasis and apoptosis.

 Research Interest
 Network
Amr Amin

Amr Amin
Professor
Department of Biology
UAE University
UAE

Biography :

Amr Amin is a Professor of Cell & Molecular Biology and a graduate faculty at UAE University. He earned his PhD in Cell & Developmental Biology from University of Illinois at Chicago and received a postdoctoral training in Molecular Genetics at University of Pennsylvania School of Medicine. After joining UAEU, Dr. Amin’s focus was redirected to the field of preventive medicine. His lab is interested in natural product-based protection against cancer. Most recently, his lab has been employing non-invasive approaches and nanoparticles to learn more about the molecular aspects of chemoprevention particularly against liver cancer. He published many research articles, reviews and book chapters in reputable journals. He also serves on the editorial boards and as a reviewer of many international journals. Dr. Amin is also the recipient of many national and international awards.
 

 Biography
Research Interest :

Biology and chemoprevention of cancer, preclinical studies, and novel plant-based anticancer drugs.

 Research Interest
 Network
Daniel S Sitar

Daniel S Sitar
Professor
Department of Medicine
University of Manitoba
Canada

Biography :

Dr. Sitar is Professor Emeritus in the Faculty of Medicine at the University of Manitoba. Academic appointments include Department of Internal Medicine (Clinical Pharmacology Section), Department of Pharmacology and Therapeutics, Department of Pediatrics and Child Health, Manitoba Institute of Child Health, and the Centre on Aging. He is also appointed in the Faculty of Pharmacy. He maintains memberships in multiple scientific societies, including Fellowship status in the American College of Clinical Pharmacology and the Gerontological Society of America. His other journal responsibilities include Editorial Board memberships for Clinical Pharmacology and Therapeutics, Clinical Pharmacology in Drug Development, and current Editor-in-Chief for the Journal of Clinical Pharmacology, the official journal of the American College of Clinical Pharmacology.

 Biography
Research Interest :

Research interests include drug disposition and effects at the extremes of age, and he has published extensively relevant to this research theme.

 Research Interest
 Network
 Acceptance Letter
Job Harenberg

Job Harenberg
Professor
Department of Clinical Pharmacology
Ruprecht-Karls University Heidelberg
Germany

Biography :

Job Harenberg is Professor of Medicine and Haemostaseology and deputy director in the Department of Clinical Pharmacology Mannheim at the University of Heidelberg, Germany. He was appointed as Full Professor of Internal Medicine at the Faculty of Medicine Mannheim since 1991. He received his medical degree in 1975 from the Faculty of Medicine of the Ruprecht-Karls-University, Heidelberg, and achieved an habilitation in the field of Internal Medicine in 1984. Professor Harenberg has worked in thrombosis and haemostasis research and in the clinical treatment of patients for more than thirty years, and has published more than 200 peer-reviewed papers. He specializes in new antithrombotic agents for use in conventional and in new indications. He has several patents on new anticoagulants for diagnostic purposes. This year, he is organizing the 18th Glycosaminoglycan Symposium with Dr Benito Casu, which will be held at Villa Vigoni near Lake Como in Northern Italy.

 Biography
Research Interest :

Laboratory research: The current main topics of laboratory research are related to the development and validation of anticoagulant effects and determination of the concentration of new anticoagulants.
Clinical research: Determination of the anticoagulants heparins, oral direct factor Xa inhibitors, oral direct factor IIa inhibitors from plasma samples of patients treated with these anticoagulants. Participation in phase II, III and phase IV clinical trials of new anticoagulants in atrial fibrillation, unstable angina, thrombosis, pulmonary embolism, prophylaxis of thromboembolism in medical patients and in patients with malignancies. Investigator initiated trials in surgical and medical patients for prophylaxis of thromboembolism using oral factor Xa inhibitors and oral factor IIa inhibitors. Analysis of a relationship between the effect of anticoagulation with phenprocoumon (determined by the international normalized ratio) and personality traits in, analysis of personality traits in relation to the willingness of patients to switch from conventional to new anticoagulants. Metaanalysis of studie with new oral anticoagulants. Pharmacokinetics of a new oral anticoagulans and other new anticoagulants.

 Research Interest
 Network
Ernst J Kuipers

Ernst J Kuipers
Professor
Erasmus MC University Medical Center
Netherlands

Biography :

Ernst J Kuipers is a gastroenterologist, and professor of medicine and chair of the Departments of Gastroenterology and Hepatology, and Internal Medicine of the Erasmus University Medical Center, Rotterdam, the Netherlands. He is associate editor of Gut, and editor of Best Practice and Research in Clinical Gastroenterology. He is/has been a member of the editorial boards of various journals including Alimentary Pharmacology and Therapeutics, American Journal of Gastroenterology, Cancer Prevention Research, and Gastroenterology, and the Cochrane group for upper gastrointestinal and pancreatic disorders.

 Biography
Research Interest :

His research interests include peptic ulcer bleeding, early neoplastic conditions of the gastrointestinal tract, and colorectal cancer screening. Ernst Kuipers is a member of the Dutch National Health Council, President of the Dutch Society of Gastroenterologists, and fellow of the American Gastroenterology Association.

 Research Interest
 Network
Mario Giorgi

Mario Giorgi
Professor
Department of Veterinary Clinics
University of Pisa
Italy
Read Interview session with Mario Giorgi

Biography :

Mario GIORGI is currently aggregate professor in Pharmacology and Toxicology at the University of Pisa (Italy). He achieved a degree in pharmaceutical chemistry in 1997 and a degree in applied pharmacology in 2001. In the same year he was employed as an assistant professor, then in 2005 as an aggregate professor. He was visiting professor in foreign institutions (Poland, Australia, South Korea, Kazakhstan, Iran, China and Israel) caring out mutual research and teaching. His main research fields are: Pharmacokinetics/Pharmacodynamic studies in different animal species; Toxicological analyses in veterinary medicine. He acts as referee for more than 40 international journals and as member of editorial board for 5 international journals. He is authors of more than 80 peer reviewed papers.

 Biography
Research Interest :

Xenobiotics
Toxicological analyses in forensic medicine
Pharmacokinetics

 Research Interest
 Network
Mohammad Abdollahi

Mohammad Abdollahi
Professor
Department of Toxicology and Pharmacology
Tehran University of Medical Sciences
Iran

Biography :

Mohammad Abdollahi (MA) is Professor of Toxicology and Pharmacology and dean of department at Tehran University of Medical Sciences (TUMS). Main expertise of MA is in Mechanistic Toxicology and Disease Models/Biomarkers, and Evidence-Based Medicine. One of the research interests of MA is the mechanisms relating chronic exposure to toxic compounds and the induction of debilitating human diseases. MA is expert in the field of oxidative stress, a biochemical/molecular mechanism which plays a role in many human debilitating diseases. MA has been President of Irantox since 2006 and director of Toxicology Examination Board since 2004. MA has been listed among top 1% top scientists of the world in the field of Pharmacology/Toxicology according to Essential Science Indicator from Thompson Reuters ISI. MA is the prizer of the IAS-COMSTECH in the field of Pharmacology and Toxicology in 2005 and a fellow of IAS since 2009. MA is one of leading scientists of OIC member countries. MA is an active member of more than 100 international academic journals and societies. MA is a correspondent to World Library of Toxicology and WHO in the fields of Toxicology of Pesticides, Poison Information Centers, and Lead Poisoning. MA is a member of scientific advisory board in OPCW. MA has published over 450 high impact full papers, and contributed to 20 books from famous publishers. Total citations of MA in textbooks and journals are over 7000. MA is Editor-in-Chief of two journals from Elsevier (Journal of Medical Hyptheses and Ideas) and BioMed Central (DARU Journal of Pharmaceutical Sciences). MA is the associate editor to the 3rd edition of the major reference textbook of Elsevier “Encyclopedia of Toxicology”. MA is also editing a new book entitled “Basic and Clinical Toxicology of Organophosphorous Compounds” for Springer.

 Biography
Research Interest :

Clinical studies, Oxidative stress, Colitis, Metabolism of glucose, Pesticides, Meta-analysis, Teratology, Epedimiology of poisonings, Mechanistic Toxicology and Pharmacology.

 Research Interest
 Network
Demiana Ibrahim Nesseem

Demiana Ibrahim Nesseem
Professor
Cairo University
Egypt

Biography :

He is the head of Physical properties Department, National Organization for Drug Control and Research. Lecturer of Pharmaceutics, at the core of University Staff (NODCAR) , Pharmaceutics Laboratory dep. Center management committee member, Bioavailability center (NODCAR).
Assistant Lecturer, at the core of University Staff (NODCAR), Pharmaceutics department, and Deputy director, Information and Training center at Pharmaco Center (NODCAR). Researcher and Information Specialist at Central Administration of Pharmacy, Information Specialist at Pharmaco Center (NODCAR) and Ministry of Health. Pharmacist (Analyst), Arab Drug Company "ADCO" , Egypt.
 

 Biography
Research Interest :

1. Hands on experience with operation, calibration, maintenance and
Troubleshooting of the sophisticated instruments like HPLC (using gradient
system and UV detector), FT-IR, and UV-visible spectrophotometer.
2. Preformulation studies and topical formulation development.
3. Drug dissolution from different drug-polymer systems, In-vitro-In vivo correlations.
4. Bioavailability and Bioequivalence studies on human volunteers to supply NODCAR with crucial information about the safety and effectiveness of marketed products.

 Research Interest
 Network
Sachin S Devi

Sachin S Devi
Director
LECOM School of Pharmacy
USA

Biography :

Dr. Devi received his BS in Pharmacy from Shivaji University, Maharashtra, India and Ph.D. in pharmacology/toxicology from The University of Louisiana at Monroe. He was a post-doctoral fellow in Center for Integrative Toxicology at Michigan State University. He served as student representative and post-doctoral liaison at Comparative and Veterinary Specialty Section of Society of Toxicology. Currently, Dr. Devi is working as Director of Curriculum and Director of Laboratory of Pharmacology and Toxicology at LECOM-School of Pharmacy, Bradenton, FL. His laboratory focuses on developing a novel treatment for acute liver failure. Dr. Devi is a member of various scientific organizations, authored book chapters, manuscripts and serves as invited reviewer on several journals.

 Biography
Research Interest :

Toxicology, Pharmacology

 Research Interest
 Network
Rajeshwar Rao Tekmal

Rajeshwar Rao Tekmal
Director
Department of Obstetrics and Gynecology
The University of Texas
USA

Biography :

Dr. Tekmal serves as managing editor of the Frontiers in Biosciences and Editorial Board member of AACR Cancer Research and Omics group Gynecology and Obstetrics. He has served as a regular member of National Institutes of Health study section. In addition, he is an ad-hoc member of numerous NIH study sections, a Department of Defense (DOD), Komen Foundation for the Cure, as well as several other national and international funding programs.

 Biography
Research Interest :

Preclinical models, actions of agonist/antagonists of hormonal therapeutic agents, nanoparticle formulations, targeted novel therapeutic agents
 

 Research Interest
 Network
John A Dani

John A Dani
Chair
Department of Neuroscience
University of Pennsylvania
USA

Biography :

Dr. Dani received his Ph.D. in Physiology from the University of Minnesota. After postdoctoral training, he joined Baylor College of Medicine where he became Professor and Director of the Center on Addiction, Learning and Memory. Dr. Dani has received a number of awards, including the Jacob Javits Neuroscience Award from the NIH. The summer of 2013 he became the Chair of the Department of Neuroscience and Director of the Mahoney Institute for Neurosciences at the University Of Pennsylvania Perelman School Of Medicine.

 Biography
Research Interest :

1. Nicotinic and Cholinergic Mechanisms
2. Addiction
3. Dopamine Mechanisms
4. Learning and Memory
5. Synaptic Plasticity

 Research Interest
 Network
Kenneth Maiese

Kenneth Maiese
Chair
Department of Neurology & Neurosciences
Rutgers New Jersey Medical School
USA

Biography :

Kenneth Maiese is Head of Translational Medicine and External Innovation, and past Professor, Chair, and Chief of Service of the Department of Neurology and Neurosciences at Rutgers. He graduated from the University of Pennsylvania Suma cum Laude with Distinction, was a Teagle and Grupe Scholar at Weill Cornell Medical College, and trained as a physician-scientist at the NIH. Dr. Maiese has received outstanding teaching awards and election to America\s Top Physicians, the Best of U.S. Physicians, and Top Doctors. He is a top cited author with continuous funding from multiple agencies such as the American Diabetes Association, the American Heart Association, the Bugher Foundation, and the NIH. Dr. Maiese holds several patents, has over 350 publications and has authored 5 books. Dr. Maiese also serves as the Editor-in-Chief, Associate Editor, or editorial board member for more than 70 journals as well as on multiple executive, technology, and scientific advisory councils.

 Biography
Research Interest :

Translational drug development, Oxidative stress, Cell signaling, Transcription factors, Apoptosis and Autophagy.

 Research Interest
 Network
David E Moody

David E Moody
Associate Director
Centre for Human Toxicology
The University of Utah
USA
Read Interview session with David E Moody

Biography :

Dr. David Moody is Research Professor in the Department of Pharmacology and Toxicology and Associate Director of the Center for Human Toxicology, a mass spectrometry bioanalytical facility within the department. His undergraduate studies were in chemistry (University of Kansas, Lawrence), and his doctorate in experimental pathology under the guidance of Janardan Reddy (University of Kansas Medical Center, Kansas City). A postdoctoral fellowship that evolved into a research scientist position with Edward Smuckler (UC San Francisco) and a research scientist position with Bruce Hammock (UC Davis) followed. He then took his current position as Associate Director and rose through the ranks from Assistant to full Research Professor. At the Center Dr. Moody has utilized the mass spectrometry facility to study the in vitro metabolism of specific drugs, most notably amphetamine, methadone, buprenorphine and oxycodone. He also provides collaborative and contractual bioanalytical services for pharmacokinetic studies on these and related drugs.

 Biography
Research Interest :

In vitro drug metabolism
Mass spectrometric quantitation of drugs and drug metabolites
Opioid toxicity
Forensic Toxicology

 Research Interest
 Network
Abeer Al-Ghananeem

Abeer Al-Ghananeem
Associate Dean
College of Pharmacy
Sullivan University
USA

Biography :

Dr. Al-Ghananeem received herB.S. Degree in Pharmacy from University of Jordan College of Pharmacy (1993), Masters and Ph.D. (1999) from the University of Kentucky, where she also completed a Post-Doctoral Training in Drug Delivery and Pharmaceutical Technology.She was a faculty member at the Department of Pharmaceutical Sciences, University of Kentucky College of Pharmacy and an associate member of the University of Kentucky Graduate Faculty. She trained few Postdoctoral fellows, graduate students, and visiting scholars. Recently, Dr. Al-Ghananeem was appointed as the Associate Dean of Research and Graduate Program.

 Biography
Research Interest :

Drug Development, Targeted Delivery, Clinical Pharmacokinetics, and Pharmaceutical Technology.

 Research Interest
 Network
Alan Prem Kumar

Alan Prem Kumar
Senior Research Scientist
Department of Pharmacology
Cancer Science Institute of Singapore
Singapore

Biography :

He is a Post-Doctoral Fellow in Sidney Kimmel Cancer Center at San Diego, California, USA, and works as a Research Fellow in Dept. of Physiology, NUS. He worked as a Research Scientist in National University Medical Institutes (NUMI), NUS.
Presently he is in Scientific Advisory Board in Bioexplore in India and Visiting Research Fellow at The University of Western Australia, Crawley, WA.
 

 Biography
Research Interest :

Diabetes and cancer are common diseases among adults worldwide. New research shows that  both hyperinsulinaemia and hyperglycemia, characteristics of type 2 diabetes, are major risk factors for a number of cancer-promotes tumor development. My area of research focuses on exploring the role of nuclear receptors, such as PPARs (peroxisome proliferator-activated receptors), ERα, HNF4α, and DEAD-box RNA helicases in the prevention and treatment of cancer and diabetes.

 

 Research Interest
 Network
Hong-Yu Li

Hong-Yu Li
Associate Professor
College of Pharmacy
The University of Arizona
USA

Biography :

Dr. Li is currently associate professor of medicinal chemistry in College of Pharmacy, University of Arizona. Dr. Li received his Ph.D. degree from the University of Tokyo. He did the postdoctoral training at Columbia University and Harvard University. Dr. Li has extensive experience in drug discovery and development, with a particular focus on Oncology. He has led medicinal chemistry teams with about twenty chemists, and collaborated with leaders in pharmacology, toxicology, pharmacokinetics, pharmacy, and intellectual property for the discovery of new experimental drugs (IND). He and his team have successfully discovered three small molecule kinase inhibitors with acceptable toxicology profile, that were tested in clinical trials. Dr. Li was the kinase platform-rational drug design leader at Eli Lilly and was responsible for the generation of kinase inhibitors. His broad expertise in the study of kinases and cancer will allow him to discover the next generation kinase inhibitors for use in cancer and Alzheimer’s disease.

 Biography
Research Interest :

Dr. Li’s research interest is drug discovery and development of kinase inhibitors for rare and/or neglected cancer diseases in a High-Throughput manner. To discover active hits, a novel type of kinase fragment library will be generated in a High-Throughput manner. This kinase fragment library will be designed to overcome most of issues concerning kinase fragment libraries. Compounds identified from the library as an active will be further optimized for better activity and toxicity profiles. The optimization will be done through the library synthesis approach, rather than the industry standard approach of solving SAR (structure-activity relationship) problems one molecule at a time. The one-by-one approach may work well in the beginning of the sequence of the drug discovery value chain, but you may run the risk of encountering the initial problems when trying to solve the next problem. One-cycle library iteration will produce a wide range of SAR information including toxicity for the next library design and production. Three to five cycle iterations of libraries will generate advanced compounds with properties to produce the desired in vivo efficacy with acceptable toxicity profile. The library design approach aided by the computer modeling and calculation will focus on solving any unforeseen SAR problems for each cycle.

 Research Interest
 Network
Irfan Rahman

Irfan Rahman
Associate Professor
University of Rochester
USA

Biography :

Irfan Rahman is an Associate Professor of Environmental Medicine and Pulmonary Medicine at the University of Rochester Medical Center, NY. His research is funded by the NIH via R01 mechanism. Dr. Rahman is an author of over two hundred (200) publications in peer-reviewed journals, and invited to write chapters in medical text books and editorials in journals. Dr. Rahman is an Associate Editor and a member of the editorial boards of several international journals. He has been serving on various NIH study section rosters since 2005. He is a full faculty member of F1000 Medicine team.

 Biography
Research Interest :

His research interests include oxidants, inflammation, senescence, regulation of redox-sensitive transcription factors, steroid resistance, and chromatin remodeling-epigenetic changes in chronic inflammatory diseases.

 Research Interest
 Network
Maximino Redondo

Maximino Redondo
Associate Professor
Department of Biochemistry and Molecular Biology
University of Malaga
Spain

Biography :

He has received his M.D. and Ph.D. in Biochemistry from the University of Granada, Spain, and completed his residency training in Clinical Biochemistry in Virgen de las Nieves University Hospital, Granada. He is Associate Professor in the Department of Biochemistry and Molecular Biology University of Malaga (Spain). He also obtained the following accreditations: European Clinical Chemist (European Communities Confederation of Clinical Chemistry), Accreditation in Human Genetic (Spanish Association of Human Genetic) and University Expert in Epidemiology and Clinical Research(University of Granada). He is Director of Hospital Tumor Registry (Marbella, Spain) and Member of the European Association of Cancer Research.

 

 Biography
Research Interest :
 Research Interest
 Network

Celestial Yap
Associate Professor
Department of Physiology
National University of Singapore
Singapore
Read Interview session with Celestial Yap

Biography :

Celestial Yap is Principal Investigator and Associate Professor at the Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore. Graduating with an MBBS degree (Singapore), she was engaged in hospital practice before embarking on PhD studies at the University of Edinburgh, United Kingdom. She set up the Cytoskeleton and Tumour Biology laboratory at NUS in 2006, which focuses on cytoskeletal derangements that promote tumour invasion and resistance to treatment. The laboratory’s interests also include signaling pathways in tumour biology, and biomarkers in human diseases including cancer and sepsis. As an academic, she is also actively involved in medical education, where she serves in several committees overseeing examinations and curriculum review, and supervises the training of medical educators.

 Biography
Research Interest :

Molecular mechanisms in human disease with a focus on cancer progression, recurrence and therapeutic resistance; biomarkers in human diseases including cancer and sepsis.

 Research Interest
 Network
Wenbo Zhan

Wenbo Zhang
Assistant Professor
Department of Neuroscience & Cell Biology
The University of Texas Medical Branch
USA
Read Interview session with Wenbo Zhang

Biography :

Wenbo Zhang, is an Assistant professor in Department of Neuroscience & cell Biology, University of Texas Medical Branch, USA.His Research Interest includes GPCR Signaling and diabetic Vascular Complications.

 Biography
Research Interest :

Dr. Zhang is an expert in the field of GPCR signaling and diabetic vascular complications.

 Research Interest
 Network
Deepak Bhatia

Deepak Bhatia
Assistant Professor
Pharmacogenomics
Bernard J Dunn School of Pharmacy
Shenandoah University
USA

Biography :

Deepak Bhatia, Ph.D. is an Assistant professor in the department of pharmaceutical sciences at Northeast Ohio Medical University and an adjunct professor in the School of Biomedical Sciences at Kent State University. Dr. Bhatia received his M.S. and Ph.D. in pharmaceutical and pharmacological sciences from West Virginia University followed by post-doctoral fellowship from City of Hope in the department of stem cells and leukemia research. During his Ph.D. he received fellowship form National Institute of Occupational Safety and Health (NIOSH). His current research is in the area of DNA damage signaling and chemoprevention. He serves as an ad-hoc reviewer for many journals and as editorial board member of international journal of pharmaceutical engineering. Dr. Bhatia also serves as an onsite evaluator for Higher Learning Commission.

 Biography
Research Interest :

The broad focus of my research is to investigate genetics and epigenetics changes in human lung cancer in response to genotoxic stress. Occupational exposure to mammalian cells elicit a variety of stress-related signals that lead to the altered expression of multiple genes involved in cell-cycle control, programmed cell death, and in some case DNA repair. Interestingly, key growth-control genes, such as the tumor suppressors p53 and RB and transcription factors such as Egr-1, Nf-kB, play central roles in some of these signaling pathways, and perturbations in their function in many human tumor cells have important implications in carcinogenesis.

 Research Interest
 Network
Gautam Sethi

Gautam Sethi
Assistant Professor
Yong Loo Lin School of Medicine
National University of Singapore
Singapore

Biography :

After completion of his Ph.D research in Cellular Immunology from Banaras Hindu University India, Dr. Sethi joined University of Texas MD Anderson Cancer Center, and worked in the area of inflammation and cancer research for his post-doctoral studies. He later joined National University of Singapore in 2008 as an Assistant Professor and is currently leading the Cancer Pharmacology program in the Department of Pharmacology.

 Biography
Research Interest :

The focus of his research over the past few years has been to elucidate the mechanism (s) of activation of transcription factors NF-κB and STAT3 by carcinogens and inflammatory agents and the identification of novel inhibitors of NF-κB and STAT3 for prevention of and therapy for cancer. From natural sources, his group has identified numerous small molecules that can suppress NF-κB and STAT3 activation and inhibit TNF/IL-6 signaling. Thus, these agents have potential treatment properties for numerous inflammatory diseases, including cancer and are not toxic. Moreover, the results his research work have so far resulted in more than hundred scientific publications in high impact factor peer reviewed journals and several international research awards.

 Research Interest
 Network
Raghu Tadagavadi

Raghu Tadagavadi
Research Associate
Department of Medicine
The Pennsylvania State University
USA

Biography :

Raghu Tadagavadi is a Junior Faculty in the Department of Medicine at Pennsylvania State University College of Medicine, PA, USA. He received PhD in Biochemistry and Molecular Biology with specialization in Immunotoxicology from Pennsylvania State University College of Medicine, PA. He has obtained graduate training in Veterinary Medicine and a Master degree in Immunology from India. He has received over four years of postdoctoral training in Immunotoxicology and Immunopharmacology at Pennsylvania State University and Emory University. Raghu is a Diplomate of the American Board of Toxicology. He also serves as reviewer and/or editorial board member for many peer reviewed journals including The American Journal of Physiology-Renal Physiology, British Journal of Pharmacology, Cytokine, Clinical Pharmacology and Biopharmaceuticals, Journal of Clinical and Cellular Immunology, Journal of Drug Metabolism and Toxicology, Journal of Clinical Toxicology, Pharmaceutical Sciences, and Plos One. Raghu’s research interests are in the areas of Immunological Toxicology and Pharmacology, and his work focuses on understanding the mechanisms by which the immune system regulates the effects of toxins and pharmaceuticals.

 Biography
Research Interest :

Immunological toxicology and pharmacology

 Research Interest
 Network
Raghavendra Gowda

Raghavendra Gowda
Research Associate
Department of Pharmacology
Hershey College of Medicine
Penn State University
USA

Biography :

Dr. Gowda’s research is focused on malignant melanoma, one of the most deadly form of skin cancer due to its high metastatic potential and rapid development of resistance to drugs targeting single protein. Although encouraging recent studies showed promising results with V600EB-Raf kinase inhibitor, development of drug resistance remains a problem. The main goal of my research is to understanding the biology and signaling pathways involved in melanoma tumor progression in order to develop next generation of therapeutic agents to treat this disease. Specially, it involves target identification and validation, discovery and development of new therapeutic agents, design and validation of nanotechnologies for drug delivery and clinical evaluation of these agents in patients.

 Biography
Research Interest :

Signaling pathways involved in melanoma

 Research Interest
 Network
Praveen Shukla

Praveen Shukla
Postdoctoral Fellow
Department of Radiology and Medicine
Stanford School of Medicine
USA

Biography :

Dr. Shukla received M.S. in Pharmacology & Toxicology from prestigious National Institute of Pharmaceutical Education & Research, India, and Ph.D. in Vascular Pharmacology and Electrophysiology from North Dakota State University, Fargo. His doctoral research work was aimed at elucidating the effects of melatonin on NO/cGMP/BKCasignaling in coronary arteries. He also worked on hTRPA1 and TRPV4 channel drug discovery program at Neuronal targets and Heart failure discovery performance unit, GlaxoSmithKline R&D, Philadelphia, USA. At present, Dr. Shukla is a cardiac & cellular electrophysiology postdoctoral fellow at Stanford University School of Medicine. In addition, he also serves as a member of the advisory board at Genetesis, LLC.

 Biography
Research Interest :

His area of research includes ion channel pharmacology, diseases modeling and drug screening using stem cell-derived cardiomyocytes and cardiac electrophysiology.In advisory capacity his role is to provide expertise in the design and execution of electrophysiological experiments aimed at delineating the specific ion channel signature underlying cardiac diseases.

 Research Interest
 Network

Yonju Ha
Postdoctoral Fellow
The University of Texas Medical Branch
USA

Biography :

I obtained a Ph.D. in Animal Physiology from Nagoya University, Japan. After I received a Ph.D, I joined to the lab of Dr. Sylvia B. Smith in Georgia Regents University for my first postdoctoral training. During my postdoctoral training with her, I studied the mechanism of neuronal protection in the diabetic retina. Currently, I am working as a postdoctoral fellow in the lab of Dr. Wenbo Zhang at the University of Texas Medical Branch, and I have focused to study of mechanism of neuronal injury in the retinal diseases such as diabetic retinopathy, ischemic retinopathy and glaucoma.

 Biography
Research Interest :
 Research Interest
 Network
Amol Suryawanshi

Amol Suryawanshi
Postdoctoral Fellow
Department of Ophthalmology
Tufts University 
USA

Biography :

Dr. Suryawanshi received his DVM degree from Bombay Veterinary College, India and MS in Biochemistry from Indian Veterinary Research Institute, India. He then completed his PhD in Comparative & Experimental Medicine at the College of Veterinary Medicine, The University of Tennessee. His doctoral research work focused on understanding the role of IL-17A and Th17 cells in herpes simplex virus 1-induced corneal immunopathology. As a postdoctoral research fellow at Tufts University School of Medicine, he is studying the role of host innate and adaptive immune response in mediating corneal pathology and vision impairment against various microbial infections of the cornea.

 Biography
Research Interest :

Host Pathogen Interaction and associated immunopathology. Infectious Blindness, Angiogenesis, Inflammation, Corneal Immunopathology, Infectious Diseases. Identifying novel molecular and cellular targets for pharmacological intervention of inflammatory conditions.

 Research Interest
 Network
Yekaterina Bor

Yekaterina Bor
Clinical Pharmacist
New Jersey City University
USA

Biography :

Dr. Yekaterina Bor received her Pharm.D. degree from Long Island University School of Pharmacy. After her graduation she completed an ASHP-accredited general pharmacy practice residency at The Brooklyn Hospital Center in Brooklyn, NY and subsequently went on to complete a cardiology specialty residency at University of Massachusetts Medical Center the following year. Dr. Bor joined Ernest Mario School of Pharmacy at Rutgers University in New Jersey as a clinical assistant professor of pharmacy practice with a clinical affiliation at Saint Barnabas Medical Center in Livingston, NJ.

 

 Biography
Research Interest :

Cardiology attendings and medical residents in providing optimal medication therapy. Her other areas of interest include: critical care, internal medicine and clinical research with an emphasis in cardiology.

 Research Interest
 Network
Gareth E Davies

Gareth E Davies
Department of Pharmaceutical Sciences
South Dakota State University
USA

Biography :

Dr. Gareth E. Davies grew up in Wales. He received his bachelor’s degree in Biological Sciences from the University of Plymouth, UK. He then completed his Ph.D in Human Molecular Genetics from the University of Cardiff in the UK. Dr. Davies has carried out post-doctoral and fellowship appointments at the University of Oxford, the National Cancer Institute of the NIH and the Medical College of Wisconsin. In 2007 Dr Davies was appointed Scientific Director of the Avera Institute of Human Behavioral Genetics, on Sioux Falls, SD. He is also an Associate Professor at SDSU College of Pharmacy and Adjunct Associate Professor, Department of Psychiatry, Sanford School of Medicine, USD.

 Biography
Research Interest :

His research interests focus on the genetics of behavioral disorders and Pharmacogenomics.

 Research Interest
 Network
Younsoo Bae

Younsoo Bae
Department of Pharmaceutical Sciences
University of Kentucky 
USA

Biography :

Dr. Younsoo Bae received his Ph.D. in Materials Science from the University of Tokyo, School of Engineering. Dr. Bae did his first post-doctoral training at the University of Tokyo, School of Engineering, and subsequently worked as a Project Research Associate, at the Center for NanoBio Integration, School of Medicine, Division of Clinical Biotechnology, the University of Tokyo. He did his second post-doctoral training at the University of Wisconsin-Madison, School of Pharmacy. Dr. Bae is currently an Assistant Professor in the Department of Pharmaceutical Sciences, College of Pharmacy, at University of Kentucky.

 Biography
Research Interest :

Dr. Bae’s current research interests involve the development of polymer nanoassemblies for controlled combination delivery of various therapeutic agents, such as anticancer drugs, nucleotide drugs and contrast agents, to solid tumors. These polymer nanoassemblies can be used for effective detection, diagnosis, and treatment of cancers at low toxicity.

 Research Interest
 Network
Shaohua Yang

Shaohua Yang
Department of Pharmacology
University of North Texas
USA

Biography :
 Biography
Research Interest :

Estrogens as neuroprotants against ischemic stroke: Neuroprotective agents and strategies have been studied for years and appear to be effective in a variety of preclinical stroke models.  One of the major focuses in basic and in clinical research in the last decade has been related to the activities of estrogens.  My research focuses on the neuroprotective effects of estrogens and related analogues, using rodent stroke models. My research has demonstrated that 17β-estradiol and several estrogen analogues exert neuroprotective effects on ischemia-reperfusion injury. 

 Research Interest
 Network
Marc A Ilies

Marc A Ilies
Temple University
USA

Biography :

Dr. Marc A Ilies was born and educated in Romania, receiving his B.Sc. degree from University of Bucharest and his M.Sc. degree from the same university, after a short stage at ENSC Lille, France, in the framework of the Francophone Teaching Module. He joined Professor Alexandru T. Balaban’s group at the Polytechnic University of Bucharest, receiving his PhD. From 1997 he was also a faculty in the Department of Chemistry, School of Biotechnologies, University of Agricultural Sciences and Veterinary Medicine in Bucharest. He followed Dr. Balaban at Texas AM University in Galveston, TX, for post-doctoral studies aimed to develop new pyridinium cationic lipids for gene delivery, in close collaboration with the groups of Drs. E. Brad Thompson and Robert Garfield from UTMB Galveston, where he was a visiting scientist. In 2004 Dr. Ilies relocated to University of Pennsylvania for postdoctoral studies in self-assembling dendrons and dendrimers with Dr. Virgil Percec and cancer pharmacology with Drs. Vladimir Muzykantov and Ian Blair. Since 2007 he is assistant professor in the Department of Pharmaceutical Sciences, School of Pharmacy, Temple University. He has published over 40 scientific papers, reviews, and book chapters, and has co-authored one US patent. He also serves in the editorial boards of two journals.

 Biography
Research Interest :

His research interests fit within the broadly-defined bio-organic and medicinal chemistry at membrane interfaces using pyridinium compounds, being focused on the development of chemical solutions for the delivery of drugs and genes. His group is currently pursuing selective carbonic anhydrase inhibitors and activators and pyridinium gene transfer systems.

 Research Interest
 Network
Dipak K Ghosh

Dipak K Ghosh
Georgia Health Sciences University
USA

Biography :

Dipak K Ghosh is a professor working in Georiga Health Sciences University. His Research includes integrated biochemical and biophsycial studies on NOS to improve knowledge in enzymes heme-containing active center, ligand binding, and regulation. In the past he worked with Dr Ilme Schlichting at Max Planck Institute for NOS structure analysis and Prof Gordon Tolin at Univ of Arizona for Laser Flash photolysis.

 Biography
Research Interest :

His overall research interest describes integrated biochemical and biophysical studies on NOS to improve our knowledge of this enzyme’s heme-containing active center, ligand binding, and regulation. During this investigation he become familiar with various techniques including microbiology, cloning, expression and purification, protein chemistry/enzymologist and biochemistry, EPR, fluorescence, UV-visible and FTIR spectroscopy and its correlation to the presently available structural information from various biophysical and crystal structure studies. In the past he worked with Dr Ilme Schlichting at Max Planck Institute for NOS structure analysis and Prof Gordon Tolin at Univ of Arizona for Laser Flash photolysis. 

 

 Research Interest
 Network
Teresa M Seefeldt

Teresa M Seefeldt
College of Pharmacy
South Dakota State University
USA

Biography :

Teresa Seefeldt is an Assistant Professor of Pharmaceutical Sciences at the South Dakota State University College of Pharmacy. She received her Pharm.D. and Ph.D. in Pharmaceutical Sciences from SDSU. She teaches in the area of pharmacology and was the recipient of the College of Pharmacy Teacher of the Year award in 2006 and the South Dakota Board of Regents Excellence in E-Learning Award in 2007. Oxidative stress is her main research focus area with particular emphasis on thiol modifications in oxidative stress states. Her current research projects involve the regulation of thiol redox state in cardiomyocytes, the development of models of thiol oxidative stress in cardiomyocytes, and thiol modifications in cancer.

 Biography
Research Interest :

Teresa Seefeldt major research interests are in the area of oxidative stress. In particular, she is interested in thiol redox state and the effects of thiol modifications on cell function. Specifically, her research interests are 1. Development of models of thiol oxidative stress in cardiomyocytes 2. Regulation of thiol redox state in cardiomyocytes 3. Caffeic acid phenethyl ester as an anticancer and chemopreventive agent 4. Inhibition of glutathione reductase as a novel mechanism to increase cancer sensitivity to chemotherapy.

 Research Interest
 Network
Syreeta L Tilghman

Syreeta L Tilghman
Division of Basic Pharmaceutical Sciences
University of Louisiana
USA

Biography :

Dr. Syreeta L. Tilghman earned a Bachelor of Science in Chemistry from the University of Maryland Eastern Shore. She received a Ph.D. in Pharmacology and Experimental Therapeutics from the University of Maryland, Baltimore where she was trained under Dr. Angela Brodie. Her predoctoral studies focused on demonstrating that upregulation of AIB1 amplified in breast cancer-1, aromatase and ER61537; estrogen receptor 61537; provide long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival. Upon completion of her doctoral studies, Dr. Tilghman carried out her post-doctoral studies with Dr. Matthew E. Burow at Tulane University in the Center for Bioenvironmental Research. Here, her research centered on identifying the mechanisms by which a novel phytoantiestrogen, glyceollin, suppresses human breast tumorigenesis. Dr. Tilghman joined Xavier University College of Pharmacy as an assistant professor of Pharmacology.

 Biography
Research Interest :

Dr. Tilghman’s research interests involve investigating the use of novel phytochemicals in endocrine resistant breast cancers.

 Research Interest
 Network
Manish Issar

Manish Issar
College of Osteopathic Medicine of the Pacific
Western University of Health Sciences
USA

Biography :

Manish Issar, is a professor working in Osteopathetic medicine of the pacific Western University of Health sciences. His Research includes pharmacokinetic and pharmacodynamics relationships in the treatment of asthma and chronic Obstructive pulmonary of diseases with focus to inhale glucocorticoids and other anti- inflammatory agents.

 Biography
Research Interest :

Study Pharmacokinetic and Pharmacodynamic (PK/PD) relationships in the treatment of asthma and chronic obstructive pulmonary of disease (COPD), with focus to inhaled glucocorticoids and other anti-inflammatory agents. Development and validation of bioanalytical assays to quantify drug concentrations in biological fluids. Study the biopharmaceutical aspects in the development of drugs with focus on inhalation route. The inhalation route of drug administration can be used to deliver drugs for systemic and/or local action. With the increase in biotechnology derived drugs such as proteins, the inhalation route is an interesting alternative to parental injection.

 Research Interest
 Network
MingMing Ning

MingMing Ning
Massachusetts General Hospital
Harvard Medical School
USA

Biography :

MingMing Ning, is a professor working in Massachusettes General Hospital, Harvard Medical School. Her Research includes patent foramen Ovale and stroke, Clinical Proteomics and biomarkers, Research for Targets of Neurovascular therapy, cardioneurology.

 Biography
Research Interest :

Acute Stroke Therapy, Cardioneurology, Patent Foramen Ovale (PFO) and Stroke, Neurocritical Care/Vascular Neurology, Clinical Proteomics and Biomarkers Research for Targets of Neurovascular Therapy.

 Research Interest
 Network
Florin Despa

Florin Despa
Department of Pharmacology
The University of California
USA

Biography :

Florin Despa, is a professor working in Department of Pharmacology, at University of California. His Research Interest includes hydrophobic interactions, amyloid formation and molecular crowding effects on protein folding and stability An important accomplishment of his past work is finding that hydrophobic forces, the main contributors to the interactions between biomolecules, can be saturated by polarization effects induced by the local aqueous environment.

 Biography
Research Interest :

I  maintain an active interest in the area of hydrophobic interactions, amyloid formation and molecular crowding effects on protein folding and stability. An important accomplishment of my past work is finding that hydrophobic forces, the main contributors to the interactions between biomolecules, can be saturated by polarization effects induced by the local aqueous environment, thus making possible the control of these interactions. The results are important in designing synthetic molecular chaperones for augmenting the repair of injured cells. Another application of this finding is the realization that isomers with increased hydrophobicity (amyloidogenic peptides) can be discriminated from normally folded proteins based on the solvation properties. This observation is currently developed into a MRI based protocol that enables the detection of embryonic amyloid entities, the early state of many degenerative diseases.

 Research Interest
 Network
Qinfeng Liu

Qinfeng Liu
Department of Pharmaceutical Sciences
Campbell University
USA

Biography :

Dr. Qinfeng Liu is an assistant professor at Campbell University College of Pharmacy & Health Sciences. She teaches several undergraduate and graduate courses in pharmaceuticals and protein analysis. Besides her enthusiasm for teaching, Dr. Liu is conducting researches in areas of disease biomarker, drug metabolism, toxicology and pharmacology using a combination of analytical methodology, particularly mass spectrometry. She received her Ph.D. in Chemistry from University of Toledo, Ohio. Before moving to Campbell, Dr. Liu was a postdoctoral fellow at Vanderbilt University Medical Center, where she investigated human proteomic markers for type 2 diabetes and lung cancer. Dr. Liu has over 10 years of research experience with expertise in biological mass spectrometry and proteomics, protein analysis, chromatography and capillary electrophoresis. Dr. Liu’s favorite pastime is to play with her lovely 7 year old daughter and 3 year old twin boys.

 Biography
Research Interest :

Bio-analysis strategies for cancer protein biomarker and early detection, drug metabolism and drug toxicology using a combination of analytical instrumentation and methodology, particularly mass spectrometry.

 Research Interest
 Network
Nathaniel A Jeske

Nathaniel A Jeske
The University of Texas
USA

Biography :

Dr. Nathaniel A. Jeske Currently, he is working as Associate Professor, Director of Research, Department of Oral & maxillofacial Surgery, University of Texas Health Science center of San Antonio,University. Based on this research and fellowship training he has received several awards and honors. He is serving as an editorial member of several reputed journals like Clinical & Experimental Pharmacology.

 Biography
Research Interest :

Pharmacology, Drug-Drug Interactions

 Research Interest
 Network
 Acceptance Letter
J Alberto Fernandez-Pol

J Alberto Fernandez-Pol
Antagoras agrobusiness
Universidad de Buenos Aires
USA

Biography :

He is in the Frontiers of Science and Technology.
He is in Science and Engineering.
He is in Professionals and Resources in Cancer.

 
 Biography
Research Interest :
A. Molecular and Clinical Oncology.
B. Molecular and Clinical Infectious Diseases.
C. Positron Emission Tomography and Cyclotron-produced radiochemicals for Clinical use in DVA Medical Center and SLU. 
 
 Research Interest
 Network
Meisheng Jiang

Meisheng Jiang
Department of Molecular and Medical Pharmacology
UCLA School of Medicine
USA

Biography :

 Dr. Meisheng Jiang received his Ph. Degree from the University of Southern California. He completed his postdoctoral fellowship training with Dr. Lutz Birnbaumer at the University of California, Los Angeles. He joined the Department of Molecular and Medical Pharmacology at UCLA and established his own independent research on G-protein and GPCR signaling.  He is currently an associate Professor at the Department of Molecular and Medical Pharmacology, UCLA.

 Biography
Research Interest :

Dr. Meisheng research focuses on three major fields, diabetes, cardiac regulation and neuroscience. They are branched out from the mechanistic study of signal transduction involving heterotrimeric G proteins in the mammalian system. G proteins couple cell surface receptors to intercellular effectors, and are the critical component in the signal cascade for cells to receive, interpret, and respond to extracellular signals. Gi/o proteins couple a variety of receptors to effectors in the body. Multiple deficiencies observed in Gi/o proteins gene knockout mice indicate that the Gi/o proteins are crucial transducers in the body. The ultimate goal of his research is to elucidate the molecular mechanisms through Gi/o signaling pathways in physiological and pathological states.

 

 Research Interest
 Network
Ting Chen

Ting Chen
The Harvard Medical School 
USA

Biography :

Dr. Ting Chen was born in Nanjing, China. He earned a B.S. in Bio-pharmaceutics at Nanjing University, China and a Ph.D. in Biochemistry & Molecular Biology at Nanjing University, China with the Best Thesis Award of Jiangsu Province.
During his Ph.D. Dr. Chen published five papers in the top toxicology and biochemistry journals during his Ph.D. career including some very prestigious journals in the world. His research has been reported in Chinese University Technology Transfer and other major Chinese national media. Due to his significant contributions, Dr. Chen has received the national prestigious award of “Hewlett-Packard Distinguished Chinese Student Scholarship”.
Dr. Chen began his academic career as a research fellow at Harvard Medical School. Now he is studying and developing high throughput screens platform for anti-cancer chemicals and siRNAs. His researches have been published in Circulation and Nature Chemical Biology.

 

 Biography
Research Interest :

The overarching goal of his research has been to developing a new class of anti-cancer therapeutics and to understand mechanisms by which N,N-diarylureas inhibit cancer cell proliferation in vitro growth of mammary tumors in vivo. Current interests are in the XBP-1 splicing mediated ER-stress pathway and its application in small molecule and siRNA screens.

 

 Research Interest
 Network
Yuliang Ma

Yuliang Ma
Department of Pharmacology
Cornell University
USA

Biography :

Dr. Yuliang Ma is an asssistant research professor of pharmacology at Weill Cornell Medical College (WCMC). He received his PhD in pharmaceutical sciences (biological mass spectrometry) from University of Antwerp, Belgium. Before moving to WCMC, Dr. Ma was Director of Proteomics Facility, Burnham Institute for Medical Research, CA (2002-2006) and a postdoctoral fellow at New York University School of Medicine (1999-2002). His research has been focused on developing and applying mass spectrometry-based proteomics and metabolomics approaches for identification, characterization, and quantification of diseases-related proteins, peptides, and biochemical metabolites such as eicosanoids.
            

 Biography
Research Interest :
 Research Interest
 Network
Feng Cheng

Feng Cheng
College of Pharmacy
University of South Florida
USA

Biography :

Education: Dr. Cheng received his first Ph.D. degree in computational medicinal chemistry at the Chinese Academy of Science (CAS) in 2003. After finishing his second PhD in bioinformatics at the University of Virginia, Dr. Cheng received his postdoctoral training at Yale University.

Professional Experience: Presently, Dr. Cheng is an Assistant Professor at the USF College of Pharmacy. Dr. Cheng has published over 30 research papers in prestigious journals including Nature. Presently, Dr. Cheng is an editor board member of Journal of Biomedical Science and Engineering and has been serving as a peer reviewer for more than ten journals, such as Journal of Theoretical Biology, Open Bioinformatics, Current Bioinformatics, and Current Computer Aided Drug Design.

 Biography
Research Interest :

Dr. Cheng is a computational biologist. His researches mainly focus on applications of genomic data and bioinformatics method in brain development and clinical research. He is also interested in computer-aided drug design.

 Research Interest
 Network
 Acceptance Letter
Hua Liu

Hua Liu
Vascular Biology Center
Georgia Health Sciences University
USA 

Biography :

Hua Liu,is a professor working in Vascular Biology Center, at Georgia Health Sciences University. His Research Interest Includes Mode of action, Pharmacokinetics and Efficacy of Anti-infectious agents in Human Veterinary Medicine.His research interest includes cell culture, Western Blotting, RNA extraction, Genotyping, Mice embryo Dissection.

 Biography
Research Interest :

Cell culture; Transient transfection; Pseudovirus production and lentiviral transduction; Cell proliferation assay; Cell migration assay; Cell death ELISA; Luciferase-dependent reporter gene assay; 3-dimensional angiogenesis assay; Aortic sprouting assay; Immunostaining on fixed cells; Protein purification; Protein quantification; Western blotting; RNA extraction; Quantitative RT-PCR; Plasmid construction; Transformation; Plasmid purification; Site-directed mutagenesis; Genotyping; Mice embryo dissection; Streptozotocin-induced diabetic model in mice; Retinal flat mount; Immunostaining on flat-mount retina and tissue section; Isolation of vascular network from retina by trypsin digestion.

 Research Interest
 Network
Thein H Oo

Thein H Oo
Anderson Cancer Center
The University of Texas
USA

Biography :

Dr. Thein H Oo received his medical degree from the Institute of Medicine II, Rangoon. He trained in internal medicine in Britain and at Albany Medical Center, New York. He underwent Oncology training at Christie Hospital, Manchester, UK, and Hematology-Oncology Fellowship at St Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, USA. After fellowship training, he joined the faculty of Tufts University School of Medicine. He was recruited to be one of the founding members of the Section of Thrombosis & Benign Hematology at the University of Texas M.D. Anderson Cancer Center, Houston in July 2010. He has published over fifty manuscripts, book chapters and abstracts. He currently serves on the editorial review board of three journals.

 Biography
Research Interest :

His interests include supportive care in cancer, hemostasis and thrombosis, bone marrow failure syndromes, consultative hematology and the graduate medical education. He participates in local, national and international educational and practice activities.

 Research Interest
 Network
Ping Ren

Ping Ren
FDA
USA

Biography :

Ren graduated from medical school in Western China University of Medical Science and completed residency training in the Beijing Medical University. Later, as an attending physician, he also participated in clinical trials for chemotherapy and photodynamic therapy for advanced gastric cancer.In 1996, Ping Ren received his Ph.D. in biomedicine from the Medical College of Ohio. After graduated, Ren pursued a fellowship in the Institute of Heart, Blood, and Lung, National Institutes of Health from 1999-2005. His clinical research was involved in the study of alteration of the gene expression profile in alveolar macrophages of idiopathic pulmonary fibrosis. In 2005, Ren was selected as a bioinformatics at the SAIC-Frederic, where he used medicine, immunology, statistic, and bioinformatics to analyze microarray data from the clinical trial of immunotherapy in HIV infected patients Dr. Ren has published over 20 research articles in peer reviewed journals and presented many research findings at national and international conferences.

 Biography
Research Interest :

Microarray, Clinical trials

 Research Interest
 Network
Prabodh Sadana

Prabodh Sadana
Department of Pharmaceutical Sciences
Northeast Ohio Medical University
USA

Biography :

Dr. Sadana received his Bachelors in Pharmacy and Masters in Pharmacology from the University of Delhi, India. Dr. Sadana received PhD in Pharmacology from the University of Tennessee in 2007. His doctoral study focused on PGC-1 transcriptional coactivators and their regulation of lipid metabolism. Dr. Sadana was awarded the predoctoral fellowship from the American Heart Association during his doctoral research at the University of Tennessee. Subsequently, Dr. Sadana underwent post doctoral training at the St.Jude Children\\\\\\\\s Research Hospital where he got exposure in preclinical assay development and high throughput drug screening. Currently, Dr. Sadana is Assistant Professor of Pharmaceutical Sciences at the Northeast Ohio Medical University. Dr. Sadana is a graduate faculty member in the school of biomedical sciences at the Kent State University. Dr. Sadana serves as a ad hoc reviewer for a number of journals.

 Biography
Research Interest :

Dr. Sadana\\\\\\\\\\\\\\\'s current research focuses on pharmacological targeting of hyperlipidemia and ischemic brain stroke. Dr. Sadana is interested in employing drug screening approaches in conjunction with drug delivery strategies to identify novel therapeutic agents and enhance the efficacy of established therapies in these disease conditions. In addition, hormonal regulation of and molecular determinants of hyperlipidemia and stroke are also areas of active investigation in Dr. Sadana\\\\\\\\\\\\\\\'s laboratory.

 Research Interest
 Network
Pavan Balabathula

Pavan Balabathula
Department of Pharmaceutical Sciences
The University of Tennessee Health Science Center
USA

Biography :

Pavan Balabathula is currently working as a Senior Research Specialist in Pharmaceutical Sciences Department at University of Tennessee Health Science Center, Memphis, TN. He conducts research and analytical studies for development of novel drug products according to federal guidelines, which includes formulation development of sterile dosage forms for new chemical entities for pre-clinical and Phase I studies, analytical studies involving drug product testing & stability testing using HPLC, UV-VIS, & DLS. He also develops and validates stability indicating assays in accordance to federal and international guidelines. He is experienced in formulation development of API delivery systems including iron oxide nanopartilces, liposomes, micelles, and solid lipid nanoparticles for treating life threatening cancer and infectious diseases.

 Biography
Research Interest :

Analytical Method Development and Validation. Formulation development of nanotechnology drug delivery systems including iron oxide nanoparticles. Liposomes, micelles, and solid lipid nanoparticles, both targeted and non-targeted.

 Research Interest
 Network
Syed A A Rizvi

Syed A A Rizvi
Department of Pharmaceutical Sciences
Southeastern University
USA

Biography :

Dr. Rizvi pursued an M.S and Ph.D combined degree program at the Center for Biotechnology and Drug Design, Department of Chemistry, Georgia State University (GSU), Atlanta, GA. While working at GSU, Dr. Rizvi was trained in the areas of Analytical Chemistry, Separation Sciences, Bioanalysis, Surfactant Chemistry, Chiral Separations of the Drugs, Trace Level Analysis (Forensic Chemistry) of Drugs in human body fluids (led to a US and International patent). Right after finishing M.S and Ph.D at the GSU, Dr. Rizvi pursued another Ph.D (under Prof. Martin J. D’Souza) at the College of Pharmacy and Health Sciences, Department of the Pharmaceutical Sciences, Mercer University (MU), Atlanta, GA in collaboration with Dr. Scott L Childs (founder and chief Scientific officer, Renovo Research, LLC). At Mercer, Dr. Rizvi was trained in the areas of Solid Dosage Formulations (direct compressed tablets), Controlled Release Formulations, Nanoparticulate System for Non-Invasive real time In Vivo Imaging, Cell-Lipid interaction Studies.

 Biography
Research Interest :

Micro and Nano-Technology for Drug Delivery, Controlled Release Formulations, Solid State Chemistry of the Drugs, Surface Chemistry, Analytical Chemistry, Soft Material Chemistry, Forensic Chemistry, Organic Chemistry, Natural Product Chemistry, Vaccinology and Immunology.

 Research Interest
 Network
Lipika Chablani

Lipika Chablani
Wegmans School of Pharmacy
St. John Fisher College
USA

Biography :

Dr. Lipika Chablani is currently Assistant Professor at Wegmans School of Pharmacy, St. John Fisher College, Rochester NY. She owns a B.S in Pharmacy from University of Mumbai, India. After completion of her B.S. in Pharmacy, she moved on to pursue a Master’s degree at Campbell University, School of Pharmacy and Health Sciences, North Carolina. Dr. Chablani is involved in co-teaching three courses at Wegmans School of Pharmacy: Applied Pharmaceutics laboratory, Principles of Pharmaceutical Sciences and Pharmaceutics. Along with teaching, she plans to foster her research interests in the field of oncology and immunology as she continues her research against breast cancer. Dr. Chablani is also an active member of AAPS, AACP and Toastmasters International.

 Biography
Research Interest :

Research interest lies in the field of nanotechnology targeted towards providing preventive and therapeutic solutions for cancer.

 Research Interest
 Network
Kim Lawson

Kim Lawson
Department of Biosciences
Sheffield Hallam University
UK
Read Interview session with Kim Lawson

Biography :

Dr. Kim Lawson BTech (Hons), PhD is a pharmacologist with an international reputation in Drug Discovery Research, gained in academia and multinational pharmaceutical industries. Kim is regularly invited as a consultant to the pharmaceutical and healthcare industries & affiliated organizations, to talk at public events & scientific conferences and to write′sexpert opinion′s articles for scientific and clinical journals. He is a member of Advisory Boards to the Fibromyalgia Association UK and FibroAction, and of the Scientific Committee of the International Centre for studies and research in Biomedicine, asbl (Luxembourg).

 Biography
Research Interest :

His research interests and expertise are focused towards i) the identification of novel targets for the development of drugs for the treatment of fibromyalgia & ii) modulation of potassium channels (BKCa, KATP, hERG, Kv7) as a therapeutic approach.

 Research Interest
 Network
Arik Dahan

Arik Dahan
Faculty of Health Sciences
Department of Clinical Pharmacology
Ben-Gurion University of the Negev
Israel

Biography :

He is an Assistant Professor in Department of Clinical Pharmacology in School of Pharmacy, Ben-Gurion University of the Negev, Beer-Sheva, Israel, and an Adjunct Assistant Professor of Pharmaceutical Sciences in Department of Pharmaceutics, College of Pharmacy, University of Michigan, Ann Arbor Michigan, USA.
Present he is working as an Editorial Board Member for World Journal of Pharmacology (WJP) and Registered Pharmacist in The Israeli Ministry of Health, Pharmacist license No. 6272.

 Biography
Research Interest :

- Physical Pharmacy and Modern Biopharmaceutics.
- Pre-clinical oral pharmacokinetic projects.
- Oral lipid based formulation development and pre-clinical mechanistic investigations.
- Oral drug delivery development and clinical bioavailability research with              Emisphere Technologies.
- Oral bioavailability research projects with Pharmos.

 Research Interest
 Network
Chiara Uboldi

Chiara Uboldi
Joint Research Centre European Commission
Italy

Biography :

Dr. Uboldi has obtained her PhD in Biology at the Westfälische Wilhelms Universität in Münster (Germany), where she has investigated the role of L-selectin in the immunopathogenesis of autoimmune experimental encephalomyelitis, an animal model for multiple sclerosis. As postdoctoral research fellow she has joined the Institute of Pathology at the University Medical Centre of the Johannes Gutenberg University in Mainz (Germany), where she has started investigating the potential in vitro toxicity exerted by nanosized materials in a model of the human alveolo-capillary barrier. Dr. Uboldi then moved, as Post-doc, at the Joint Research Centre of the European Community (Ispra, Italy), where she continues investigating nanoparticles and their potential cytotoxicity, genotoxicity and morphological transformation in vitro, in addition to their uptake and intracellular localization.

 Biography
Research Interest :

In vitro toxicity (cytotoxicity, genotoxicity, morphological transformation), Nanomaterials, Microscopy and Cytokine release.

 Research Interest
 Network
Roberto Canitano

Roberto Canitano
Division of Child Neuropsychiatry
University of Siena
Italy

Biography :

Born in Rome, Italy, 14/03/1962. Present position: Research Clinician at the Division of Child Neuropsychiatry at the University Hospital of Siena. The Division is a referral centre for Autism and Allied disorders in Italy. Adjunct Professor of Child Neuropsychiatry at the School of Medicine of the University of Siena, Italy.

 Biography
Research Interest :

Research interests are the following: neurophysiology and epilepsy in ASD (Autism Spectrum Disorders), pharmacotherapy of ASD, comorbidity in ASD.

 Research Interest
 Network
 Acceptance Letter
Sanchez Bruni Sergio

Sanchez Bruni Sergio
Fabian Laboratory of Pharmacology
Universidad Nacional del Centro de la Pcia Tandil
Argentina

Biography :

Sanchez Bruni Sergio, is a professor working in Fabian Laboratory of Pharmacology, at Argentina. His Research Interest Includes Mode of action, Pharmacokinetics and Efficacy of Anti-infectious agents in Human Veterinary Medicine.

 Biography
Research Interest :

Pharmacology and Therapeutics, Mode of Action, Pharmacokinetics and Efficacy of anti-infectious agents in Human and Veterinary Medicine. Immune-pharmacology of anti-infectious agents.

 Research Interest
 Network
 Acceptance Letter
Gabriela Beatriz Acosta

Gabriela Beatriz Acosta
University of Buenos Aires
Argentina
Read Interview session with Gabriela Beatriz Acosta

Biography :

Prof/Dr.Gabriela Beatriz Acosta has received her PhD in Buenos Aires University (Pharmacology area) during the period of 1988-1993. She has successfully completed his Administrative responsibilities as Researcher in Institute of Pharmacological Research (ININFA), National Scientific and Technologic Research Council (CONICET) and University of Buenos Aires (UBA). She is serving as an editorial member of several reputed journals like as Brain Research, Neuroscience Letters, Brain Research Bulletin, Neurochemistry International, Int. J. Developmental Neuroscience, Current Chemical Biology, and so on.

 Biography
Research Interest :

Neuropharmacology
Neuroscience
Human Health

 Research Interest
 Network
S K Sahoo

S K Sahoo
Laboratory of Nanomedicine
Institute of Life Sciences
Bhubaneswar
India

Biography :

Dr. Sahoo is a scientist at the Institute of Life Sciences, Bhubaneswar, India. Dr. Sahoo received his M.Sc. degree from the University of Delhi, Delhi in 1994 and Ph. D. in 1999 from the same University. He served as a JSPS Postdoctoral fellow at the Department of Microbiology, School of Medicine, Kumamoto University, Kumamoto, Japan from (1999-2001) followed by a four year postdoctoral fellowship at the Nebraska Medical Centre, Omaha, USA from 2001-2005. During his postdoctoral studies, he has acquired good knowledge and experience in the art of making different nanotechnology based drug delivery systems for therapeutic use. Dr Sahoo is one of the first inventors in India whose nanotechnology based patented formulation on anticancer drug (taxol) delivery has been purchased by an Indian Pharmaceutical industry and very soon it will be in the market.
 

 Biography
Research Interest :

His research interest is nanotechnology based drug delivery system mainly in the field of cancer.

 Research Interest
 Network
 Acceptance Letter

WenHua Zheng
Associate Professor
Faculty of Health Science
University of Macau
China

Biography :

Wenhua obtained his Medical Degree and M. Sc. in Pharmacology at Zhongshan (Sun Yat-sen) University of Medical Science in Guangzhou China, and a Ph. D. in the Departments of Pharmacology at McGill University, Montreal, Canada. Wenhua was Awarded several post-doctoral research training positions in prestigious research institutes and universities around the world (Visiting Fellow the NIH 1993-96, Visiting Scientist at University of Rochester, NY in 92 and Post-Doctoral Fellow at McGill University in 1996). He became a professor at Sun Yat-sen University in 2006. In 2015, Wenhua joined the Faculty of Health Science at University of Macau

 Biography
Research Interest :

Neuro- and ocular pharmacology
Alzheimer's disease
new drug developments

 Research Interest
 Network
 Acceptance Letter
Shih-Jung LIU

Shih-Jung LIU
Professor
Chang Gung University
Taiwan

Biography :

Shih-Jung LIU, is a professor in Chang Gung University.He has received his Ph.D from Univeristy of Wisconsin-Madisonin year 1992.Dr. Liu has received post doctoral fellowship from McMaster University, Canada in year 1993.Dr. Liu serves as an Editor for many reputed journals like Journal of Polymer Engineering,International Polymer Processing. Dr. Liu has received awards like morand Lambla award.

 Biography
Research Interest :

Nanofibers, Bioabsorbable medical devices, Drug delivery, Tissue engineering

 Research Interest
 Network
 Acceptance Letter
Varun  Khurana

Varun Khurana
Formulation Scientist at INSYS Therapeutics
Chandler, USA

Biography :

Varun Khurana has completed his Ph.D from University of Missouri Kansas City. He has done B. S. in Pharmacy from Guru Gobind Singh Indraprastha University New Delhi, India.

 Biography
Research Interest :

Pharmaceutical Sciences,Sublingual sprays,New Drug Application

 Research Interest
 Network
Kiyoshi Kikuchi

Kiyoshi Kikuchi
Department of Physiology/ Department of Neurosurgery
Kurume University School of Medicine
67 Asahi-machi, Kurume, Fukuoka,
Japan

Biography :

Kiyoshi Kikuchi, DDS, MD is an assistant professor working in Department of Physiology and Neurosurgery, Kurume University School of Medicine, Japan. He is also a visiting assistant professor in Department of Systems Biology in Thromboregulation, Kagoshima University Graduate School of Medical and Dental Sciences, Japan. He is also a board certified neurosurgeon in The Japan Neurosurgical Society.

 Biography
Research Interest :

 His research interest includes neurology, neurosurgery.

 Research Interest
 Network
 Acceptance Letter
Zhaoqian Liu

Zhao-Qian Liu
Professor of Pharmacology,
Central South University
China

Biography :

Professor Liu has got more than 15 national and province grants in recent five years. He has published 142 SCI papers on pharmacogenetics and pharmacogenomics field published in abroad journals include Pharmacogenetics and genomics, Nucleic Acids Research, Clinical Pharmacol Ther, Clinical Cancer Research etc. Professor Liu is now focusing on the research of basic and clinical applications of pharmacogenetics and pharmacogenomics on major diseases such as diabetes, epilepsy, and malignant tumor.

 Biography
Research Interest :

Pharmacogenetics and pharmacogenomics,,Cancer Research

 Research Interest
 Network
Cody J. Peer

Cody J. Peer
Clinical Pharmacology Program
National Cancer Institute, NIH
USA

Biography :

Dr. Peer earned his BS in Chemistry from Dickinson College (2005), a PhD in Pharmacology and Pharmaceutical Sciences from West Virginia University (2009), and more recently, a Masters in Pharmacometrics (2015). In 2009, he joined the Clinical Pharmacology Program at the National Cancer Institute (NCI) in Bethesda, MD as a postdoctoral fellow. Since 2012, Dr. Peer has been in a Research Fellowship position and has overseen the bioanalytical operations and pharmacometric data analysis within the NCI Clinical Pharmacology Program.

 Biography
Research Interest :

Bioanalytical chemistry, Drug metabolism and transport, Pharmacokinetics/pharmacodynamics (PK/PD) modeling and simulation, Pharmacogenomics, and Pharmacometric analyses.

 Research Interest
 Network
 Acceptance Letter
TAWFIK M. ALHUSSAINY

TAWFIK M. ALHUSSAINY
University of Petra Amman
Jordan

Biography :

Dr. Tawfik Mustafa Alhussainy has completed his Ph.D at the age of 32 years from State university of New York at Buffalo and postdoctoral studies from Roswell Park memorial institute at Buffalo, New York. He is the chairman of department of Pharmacology and Biomedical Sciences at many Iraqi and Jordanian universities, a pharmaceutical consulting scientist for drug bioequivalence center (royal scientific society-Amman), and pharmaceutical consultant of Deem-Pharma (GXPs and licensing professionals).He has published more than 24 papers in reputed journals and serving as an editorial board member of development in pharmaceutics

 Biography
Research Interest :

His research interests include developmental Pharmacology and toxicological evaluation of new drugs

 Research Interest
 Network
 Acceptance Letter
 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version